Why corporate event data matters & how it moves the market.

Corporate Events Data — Time for a Closer Look

Publicly traded companies are scrutinized more than ever today. Information about them is dissected and fed into investors’ models and trading strategies the instant it becomes available. When signals are detected, they trigger actions, often in microseconds. So having better information sooner is the name of the game.

Read More »

Digital Turnaround – The Growing Importance of Face-to-Face Investor Conferences

A recent article from CNBC shows that asset managers and hedge funds are becoming increasingly reluctant to pay for analyst research reports that they once relied on so heavily. In fact, data shows a 25% decrease from client spend on reports compared to a year earlier.  While the importance and need for in-depth research and insight is by no means diminishing, the means in which traders are consuming and obtaining analyst intelligence is changing in a somewhat surprising way.

Read More »

Why Investors and Traders Need to Track PDUFA Dates

With the strong comeback of the biotech sector in 2017, now is as good a time as any to consider the corporate event data that can affect volatility. Although event data can range from FDA drug approval dates and FDA Advisory Committee meetings to investor conferences and analyst days, in this post, I’d like to focus on FDA drug approval dates.

Read More »

Corporate ‘Body Language’ and How to Capitalize on It

We all use non-verbal forms of communication with our posture, gestures and facial expressions. Sometimes it’s used consciously and purposefully, such as when a detective interrogates a suspect.  But most often, it’s done subconsciously, like when a hiring manager is assessing a job candidate.

Read More »

WSH Corporate Event Research 2016 Highlights

For 14 years, Wall Street Horizon has focused on providing accurate corporate event data – because we know that corporate events impact volatility.  For example, recent independent academic studies have demonstrated that changes in earnings announcement dates can affect alpha.

Read More »

Early 2016 Outlook Report – Upcoming Drug Catalysts

For the past couple weeks I’ve been writing on this blog and in our newsletter about FDA drug approval dates (PDUFA dates) and the impact that these catalysts can have on a drug manufacturer’s stock price.  This week I thought I would let our partner Informa do most of the talking.  And why not, considering their opinions successfully predicted 75% of the catalyst outcomes that occurred in Q4 2015!

Read More »

Corporate Event Survey Results

Wall Street Horizon polled the investment community with a range of questions on corporate events.  The results of the 2016 Corporate Event Research Survey reinforce that corporate events are critical to trading.

Read More »